ReGrasp HSE1
ReGrasp HSE1 is a medical device (FDA Class II) made by Rehabtronics, Inc., cleared under FDA 510(k) K153163 on 7 Apr 2016 and listed in FDA GUDID since 29 Aug 2017 (UDI-DI 17540176030079), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number17540176030079 | Date29 Aug 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK153163 | Date7 Apr 2016 | StatusActive |
Official records
- AccessGUDID record 17540176030079
- FDA 510(k) database K153163
From the FDA record
- Device description
- ReGrasp Electrode Set
- MRI safety
- MR Unsafe
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K153163 decided 7 Apr 2016 Active
- FDA GUDID UDI-DI 17540176030079 listed 29 Aug 2017 Listed
Timeline
- Cleared FDA 510(k) K153163
- Listed FDA GUDID 17540176030079
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- ReGrasp
- Generic name
- Physical therapy transcutaneous neuromuscular electrical stimulation system
- Model / reference
- HSE1
- Primary DI / UDI-DI
- 17540176030079
- 510(k) Number
- FDA product code
- IPF, GZI
- GMDN term
- Physical therapy transcutaneous neuromuscular electrical stimulation system
- Device class
- Class II
- Regulation number
- 890.5850, 882.5810
- GUDID distribution status
- In Commercial Distribution
- MRI safety
- MR Unsafe
Similar devices in this category
Other devices filed under Physical therapy transcutaneous neuromuscular electrical stimulation system.